Pure Global

M. Tuberculosis drug-resistant complex qualitative test - Vietnam Registration 2400497ĐKLH/BYT-HTTB

Access comprehensive regulatory information for M. Tuberculosis drug-resistant complex qualitative test in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2400497ĐKLH/BYT-HTTB and manufactured by Hain Lifescience GmbH. The authorized representative in Vietnam is CÔNG TY TNHH B.C.E VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2400497ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2400497ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

M. Tuberculosis drug-resistant complex qualitative test
VN: Thuốc thử xét nghiệm định tính phức hợp M. Tuberculosis đa kháng thuốc
GenoType MTBDRplus VER 2.0
Risk Class TTBYT Loại C

Registration Details

2400497ĐKLH/BYT-HTTB

000.00.04.G18-220714-0018

GenoType MTBDRplus VER 2.0

304A/30496A

Company Information

GERMANY

Hain Lifescience GmbH

Technical Details

GenoType MTBDRplus VER 2.0 is an in vitro qualitative test to determine the complex of Mycobacterium tuberculosis and the ability to resist rifampicin (RMP) and/or isoniazid (INH) from clinical positive or positive lung samples and culture samples.

Dates and Status

Apr 10, 2024